跳至主要内容
临床试验/NL-OMON48971
NL-OMON48971已完成不适用

SURVive: investigating new imaging criteria for non-operative treatment following neoadjuvant chemoradiation in rectal cancer patients - Novel imaging criteria after neoadjuvant therapy rectal cancer.

Heelkunde0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with rectal cancer who are eligible for treatment with neoadjuvant
  • chemoradiation
  • Patients treated in the LUMC, HMC, Alrijne or GHZ.
  • Age 18 years and older;
  • Willing to participate in all aspects of the study

排除标准

  • Patients with rectal cancer, receiving chemoradiation as part of the TESAR
  • Diabetes mellitus
  • Claustrofobia (low dose benzodiazepines are allowed);
  • Prior radiotherapy to the pelvis
  • If female and fertile: signs and symptoms of pregnancy or a positive pregnancy
  • test / breast-feeding (a formal negative pregnancy test is not obligatory);
  • Presence of any psychological, familial, sociological or geographical condition
  • potentially hampering compliance with the study protocol and follow-up schedule
  • Contraindications for Magnetic Resonance Imaging
  • Patient has evidence of infection in the 14 days prior to the FDG-PET/CT scan
  • localised to the lower abdomen, pelvic region, lower back, inguinal region;
  • Inability to tolerate lying supine for the duration of an FDG-PET/CT
  • examination (~30min)

研究者

发起方
Heelkunde

相似试验